BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock.Halper Sadeh encourages BioLife shareholders to click here to learn more about their...
Business Wire
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +500.00% and +1.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
BioLife Solutions Reports Second Quarter 2026 Financial Results
BioLife Solutions Reports Second Quarter 2026 Financial Results BioLife Solutions Reports Second Quarter 2026 Financial Results PR Newswire BOTHELL, Wash., Aug. 6, 2026 Total revenue of $28.5 million, up 21% over Q2 2025GAAP gross margin of 64% and non-GAAP adjusted gross margin of 65%GAAP net...
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD PR Newswire NEW YORK, July 29, 2026 NEW YORK, July 29, 2026 /PRNewswire...
PR Newswire
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders? Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 28, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders? Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 23, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
RGEN's $1.5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopreservation products and expected revenue and EPS benefits.
Zacks
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) PR Newswire NEW YORK, July 22, 2026 NEW YORK, July 22, 2026...
PR Newswire
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire MILWAUKEE, July 22, 2026 MILWAUKEE...
PR Newswire
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock. Halper Sadeh encourages BioLife shareholders to click here to learn more about their...
Business Wire